Type 2 Diabetes Study of Once-Weekly Insulin Treatment Now Enrolling Patients
News
PhaseBio Pharmaceuticals, Inc., a biopharmaceutical company focused on therapies based on biopolymers for metabolic and cardiopulmonary conditions, recently announced the start of a Phase 2a clinical trial to assess the ... Read more